SMaRT oncology-2: a two arm parallel group randomised controlled trial to determine the effectiveness and cost-effectiveness of adding a complex intervention for major depressive disorder ('Depression Care for People with Cancer') to usual care, compared to usual care alone in cancer patients

Key information made simple

This study is looking at whether Patients will be randomised to receive 'usual care' or 'usual care' plus "Depression Care for People with Lung Cancer" can help people with Depression in with cancer, Mental and Behavioural Disorders, or Reaction to severe stress and adjustment disorders. Participants take part in Patients will be randomised to receive 'usual care' or 'usual care' plus "Depression Care for People with Lung Cancer" and complete follow-up assessments. Some participants may receive usual care instead of the study treatment, and direct benefit is not guaranteed.

Registry reference

This page links back to the public source record so people can verify details directly with the registry and research team.

If you want the full study description, eligibility criteria, locations, and sponsor information in the original format, this is the place to check before taking the next step.